Want to see HK:2327 full AI Analyst Report?
Meilleure Health International Industry Group Limited (2327) Ratios
Meilleure Health International Industry Group Limited Ratios
HK:2327's free cash flow for Q2 2026 was $11.97M. For the 2026 fiscal year, HK:2327's free cash flow was increased by $0.00 and operating cash flow was $11.97M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.81 | 4.35 | 4.10 | 6.73 | 7.90 |
| Quick Ratio | 1.77 | 2.72 | 2.91 | 4.77 | 5.41 |
| Cash Ratio | 0.06 | 0.23 | 0.47 | 1.54 | 2.46 |
| Solvency Ratio | 0.07 | 0.07 | 0.10 | 0.06 | 0.21 |
| Operating Cash Flow Ratio | -0.14 | 1.19 | -0.61 | 0.32 | -0.75 |
| Short-Term Operating Cash Flow Coverage | -0.18 | 2.27 | -0.86 | 0.55 | -1.43 |
| Net Current Asset Value | $ 448.42M | $ 221.01M | $ 475.89M | $ 537.84M | $ 569.32M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.18 | 0.18 | 0.15 | 0.10 |
| Debt-to-Equity Ratio | 0.31 | 0.25 | 0.24 | 0.19 | 0.12 |
| Debt-to-Capital Ratio | 0.23 | 0.20 | 0.19 | 0.16 | 0.11 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.15 | 0.10 | 0.11 | 0.07 |
| Financial Leverage Ratio | 1.45 | 1.39 | 1.35 | 1.29 | 1.22 |
| Debt Service Coverage Ratio | -0.06 | 0.46 | 0.33 | 0.53 | 1.25 |
| Interest Coverage Ratio | -1.05 | -0.37 | 3.45 | 2.82 | 6.35 |
| Debt to Market Cap | 0.35 | 0.25 | 0.29 | 0.20 | 0.08 |
| Interest Debt Per Share | 0.10 | 0.08 | 0.08 | 0.06 | 0.04 |
| Net Debt to EBITDA | -41.88 | 4.72 | 2.67 | 0.69 | -0.94 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.97% | 57.04% | 60.39% | 55.68% | 39.89% |
| EBIT Margin | -26.59% | 108.31% | 53.16% | 25.72% | 41.56% |
| EBITDA Margin | -23.59% | 111.53% | 55.21% | 46.26% | 42.97% |
| Operating Profit Margin | -26.59% | -7.61% | 30.44% | 26.89% | 21.05% |
| Pretax Profit Margin | 83.62% | 89.59% | 40.98% | 21.17% | 33.87% |
| Net Profit Margin | 104.01% | 64.09% | 31.58% | 14.86% | 23.84% |
| Continuous Operations Profit Margin | 104.05% | 63.24% | 29.77% | 14.83% | 23.89% |
| Net Income Per EBT | 124.38% | 71.54% | 77.06% | 70.21% | 70.39% |
| EBT Per EBIT | -314.46% | -1178.02% | 134.60% | 78.73% | 160.93% |
| Return on Assets (ROA) | 2.09% | 1.95% | 2.41% | 1.04% | 3.47% |
| Return on Equity (ROE) | 3.04% | 2.70% | 3.26% | 1.35% | 4.22% |
| Return on Capital Employed (ROCE) | -0.67% | -0.26% | 2.67% | 2.05% | 3.27% |
| Return on Invested Capital (ROIC) | -0.43% | -0.17% | 1.75% | 1.37% | 2.23% |
| Return on Tangible Assets | 2.09% | 1.95% | 2.43% | 1.05% | 3.51% |
| Earnings Yield | 3.53% | 2.74% | 4.05% | 1.47% | 2.95% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.27 | 1.86 | 1.27 | 1.18 | 2.75 |
| Payables Turnover | 55.33 | 2177.10 | 2560.70 | 1235.65 | 1748.30 |
| Inventory Turnover | 0.04 | 0.08 | 0.19 | 0.20 | 0.55 |
| Fixed Asset Turnover | 11.14 | 12.92 | 30.60 | 10.48 | 44.56 |
| Asset Turnover | 0.02 | 0.03 | 0.08 | 0.07 | 0.15 |
| Working Capital Turnover Ratio | 0.06 | 0.08 | 0.17 | 0.15 | 0.31 |
| Cash Conversion Cycle | 9991.89 | 4503.88 | 2188.22 | 2153.03 | 795.79 |
| Days of Sales Outstanding | 160.91 | 196.21 | 286.61 | 308.56 | 132.56 |
| Days of Inventory Outstanding | 9837.57 | 4307.84 | 1901.75 | 1844.76 | 663.44 |
| Days of Payables Outstanding | 6.60 | 0.17 | 0.14 | 0.30 | 0.21 |
| Operating Cycle | 9998.48 | 4504.05 | 2188.36 | 2153.32 | 796.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | 0.05 | -0.03 | 0.01 | -0.02 |
| Free Cash Flow Per Share | -0.01 | 0.05 | -0.03 | 0.01 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | -2.17 | 11.43 | -2.06 | 41.02 | -12.78 |
| Capital Expenditure Coverage Ratio | -85.80 | 1429.91 | -165.04 | 41.02 | -12.78 |
| Operating Cash Flow Coverage Ratio | -0.13 | 0.62 | -0.46 | 0.17 | -0.49 |
| Operating Cash Flow to Sales Ratio | -1.37 | 3.72 | -1.06 | 0.36 | -0.33 |
| Free Cash Flow Yield | -4.70% | 15.89% | -13.64% | 3.47% | -4.39% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 28.49 | 36.54 | 24.66 | 68.02 | 33.88 |
| Price-to-Sales (P/S) Ratio | 29.49 | 23.42 | 7.79 | 10.11 | 8.08 |
| Price-to-Book (P/B) Ratio | 0.86 | 0.99 | 0.80 | 0.92 | 1.43 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -21.28 | 6.29 | -7.33 | 28.80 | -22.76 |
| Price-to-Operating Cash Flow Ratio | -21.53 | 6.29 | -7.38 | 28.09 | -24.54 |
| Price-to-Earnings Growth (PEG) Ratio | 1.61 | -1.74 | 0.19 | -0.98 | -1.25 |
| Enterprise Value Multiple | -166.90 | 25.72 | 16.78 | 22.55 | 17.85 |
| Enterprise Value | 1.44B | 1.45B | 1.20B | 1.25B | 1.94B |
| EV to EBITDA | -166.90 | 25.72 | 16.78 | 22.55 | 17.85 |
| EV to Sales | 39.37 | 28.68 | 9.26 | 10.43 | 7.67 |
| EV to Free Cash Flow | -28.41 | 7.71 | -8.72 | 29.70 | -21.62 |
| EV to Operating Cash Flow | -28.74 | 7.70 | -8.77 | 28.98 | -23.31 |
| Tangible Book Value Per Share | 0.31 | 0.29 | 0.30 | 0.32 | 0.33 |
| Shareholders’ Equity Per Share | 0.31 | 0.29 | 0.31 | 0.32 | 0.34 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.29 | 0.27 | 0.30 | 0.29 |
| Revenue Per Share | 0.01 | 0.01 | 0.03 | 0.03 | 0.06 |
| Net Income Per Share | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
| Tax Burden | 1.24 | 0.72 | 0.77 | 0.70 | 0.70 |
| Interest Burden | -3.14 | 0.83 | 0.77 | 0.82 | 0.82 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.85 | 0.62 | 0.19 | 0.25 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | -0.01 | -0.01 | 0.01 |
| Income Quality | -1.64 | 5.81 | -3.34 | 1.70 | -0.97 |
Currency in HKD